Related content

Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension—CORRIGENDUM

By  

CNS Spectrums, Vol. 22, Iss. 4, 2017-05 ,pp. : 373-373

Cambridge University Press

Access to resources Recommend Favorite

Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study

By  

CNS Spectrums, Vol. 22, Iss. 2, 2017-03 ,pp. : 236-245

Cambridge University Press

Access to resources Recommend Favorite

Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis

By  

CNS Spectrums, Vol. 22, Iss. 2, 2017-03 ,pp. : 228-235

Cambridge University Press

Access to resources Recommend Favorite

Mixed features in major depressive disorder: diagnoses and treatments

By  

CNS Spectrums, Vol. 22, Iss. 2, 2017-05 ,pp. : 155-160

Cambridge University Press

Access to resources Recommend Favorite

Treatment of Panic Disorder with Agoraphobia: Randomized Placebo-Controlled Trial of Four Psychosocial Treatments Combined with Imipramine or Placebo

By Marchand Andre   Coutu Marie-France   Dupuis Gilles   Fleet Richard   Borgeat Francois   Todorov Christo   Mainguy Nicole  

Cognitive Behaviour Therapy, Vol. 37, Iss. 3, 2008-09 ,pp. : 146-159

Routledge Ltd

Access to resources Recommend Favorite